Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Teva Pharmaceutical Industries Ltd (NYSE:TEVA), Perrigo And Sun Pharma To Bid For Dem Unit Of Bayer

Andy Parker - September 22, 2016

CVS Health Corp (NYSE:CVS) Study Reveals 66% of Americans Believe That Flu Shots Work

Clovis

What’s Next For Seres Therapeutics Inc (NASDAQ:MCRB)?

GlaxoSmithKline plc (ADR)(NYSE:GSK) Axes More Than 30 Drug-Research Projects

Agilent Technologies Inc (NYSE:A) Takes Former Employees To Court Over Claims Of IP Infringement

Allergan Plc

Allergan Plc (NYSE:AGN) Launches Campaign To Fight Preventable Blindness In America

Andy Parker - February 8, 2017 0

Here’s Why Medivation Inc (NASDAQ:MDVN) and Genocea Biosciences Inc (NASDAQ:GNCA) Gained...

- April 1, 2016 0

FDA Endorses Sanofi SA (NYSE:SNY) iGlarLixi

- May 26, 2016 1

Looking Ahead To The Potentially Game Changing TESARO Inc (NASDAQ:TSRO) Data

- September 13, 2016 0
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

BioCryst Pharmaceuticals’s (NASDAQ:BCRX) Study On Genetic Disorder Fails

Carol Harper - February 8, 2016 0
Shire Hemophilia

For Shire PLC (ADR) (NASDAQ:SHPG) Securing Hemophilia Market With Long Acting...

David Rich - January 6, 2017 0

Pfizer, Inc. (NYSE:PFE) Hospira Launches LifeCare PCA 7.0 Infusion System

Andy Parker - May 20, 2016 0
recovery

Why The Mast Therapeutics Inc (NYSEMKT:MSTX) Dip Might Be An Opportunity

- September 14, 2016 0
Bristol-Myers Squibb Co

Here’s Why Bristol-Myers Squibb Was So Kind To Nektar In The...

- February 16, 2018 0
platelet

What We’re Looking For From The Upcoming Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)...

- August 23, 2016 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 13, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 6, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

March 29, 2026

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019